LIPID PROFILE IN SUDDEN SENSORINEURAL HEARING LOSS- A PROSPECTIVE STUDY

Background: Sudden sensorineural hearing loss (SNHL) is sensorineural hearing loss of 30 dB or more over at least three contiguous audiometric frequencies that develop over a period of few hours to three days. The purpose of study is to make a protocol for treatment.Methods: 30 cases of sudden SNHL who presented to OPD of Government Medical College, Miraj between December 2015 to April 2017 were included. Detailed history taking and ENT examination was done. All patients were admitted and started on intravenous methylprednisolone. If hearing improvement was not observed, intratympanic methylprednisolone (ITS) was administered. Results: 50% patients had recovery with intravenous Methylprednisolone and 50% had no recovery. “No recovery” patients were subjected to ITS, of which 20% had complete, 30% partial and 50% no recovery. Among no recovery patients of ITS, 10% had hearing loss greater than 90 dB with improvement rate of 0%; 40% had hearing loss of 90 - 50 dB with improvement rate of 50%; 50% had hearing loss of 50-30 dB with improvement rate of 60%. Among 15 cases of ITS, mean number of days between onset of symptom and starting ITS was 13 days for complete recovery patients; 17.3 days for partial or slight recovery; 20.6 days for no recovery.Conclusions: Hearing loss less than 90 dB and earlier ITS has positive influence on hearing recovery. Systemic steroids are currently the mainstay of initial treatment. ITS is an effective treatment modality for patients who fail to respond to systemic steroids.

Download Full-text

Sensorineural hearing loss and Kawasaki disease: A prospective study

American Journal of Otolaryngology ◽

10.1053/ajot.2001.26495 ◽

2001 ◽

Vol 22 (5) ◽

pp. 343-348 ◽

Cited By ~ 36

Author(s):

P.Daniel Knott ◽

Lisa A. Orloff ◽

Jeffrey P. Harris ◽

Robert E. Novak ◽

Jane C. Burns

Keyword(s):

Hearing Loss ◽

Kawasaki Disease ◽

Prospective Study ◽

Sensorineural Hearing Loss ◽

Sensorineural Hearing ◽

A Prospective Study

Download Full-text

Association of Glycosylated Hemoglobin A1c Level With Sudden Sensorineural Hearing Loss: A Prospective Study

Frontiers in Endocrinology ◽

10.3389/fendo.2021.763021 ◽

2021 ◽

Vol 12 ◽

Author(s):

Ying Shen ◽

Zhong Zheng ◽

Lili Xiao ◽

Chengqi Liu ◽

Jingyi Guo ◽

...

Keyword(s):

Hearing Loss ◽

Sensorineural Hearing Loss ◽

Hba1c Level ◽

Hemoglobin A1c ◽

Glycosylated Hemoglobin ◽

Sudden Sensorineural Hearing Loss ◽

Sensorineural Hearing ◽

Diabetic Patients ◽

Glycosylated Hemoglobin A1c ◽

A Prospective Study

Glycosylated hemoglobin A1c (HbA1c) level has strong relevance to microvascular disorders, which are also thought to be the current main aspect of sudden sensorineural hearing loss (SSNHL), so we aim to elucidate the association of the HbA1c level with the severity, types, and prognosis of SSNHL. In this study, comparative analyses based on propensity score matching of the severity, types, and prognosis of SSNHL with the HbA1c level in 116 patients diagnosed as SSNHL were conducted, where they were divided into diabetes mellitus (DM) group and non-DM group. We finally found that, among patients with SSNHL, diabetic patients had a higher HbA1c level, more severe hearing loss, and poorer prognosis than non-diabetic patients. The HbA1c level was found to be significantly correlated with the severity and types of SSNHL, while no strong relevance was found between the higher HbA1c level and the poorer prognosis of SSNHL.

Download Full-text